DCGI approves MSD India’s Keytruda for treating cervical and esophageal cancers
Keytruda is now approved for 10 indications in six different types of cancers in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster…
The DCGI's approval came following recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control…
Tergene Biotech gets CDSCO’s recommendation for PCV15 vaccine
The PCV15 vaccine has been developed by Tergene Biotech and manufactured at AuroVaccines, a wholly-owned subsidiary of Aurobindo…
India says samples taken from pharma firm linked to Gambia deaths meet required standards
Indian health authorities announced a production halt at Maiden Pharma's factory in Sonepat in northern India in October after a…
DCGI gives nod to Serum Institute’s ebola vaccine for export to Uganda
The vaccine has been developed by the Serum Institute of India (SII), in collaboration with the Oxford University, UK. According…
Dr VG Somani gets another three-month extension for his post as DCGI
He continues to hold the post with immediate effect from 16th November, 2022, until further order
DCGI allows Serum Institute to export malaria vaccine to UK: Report
Currently, only one vaccine against malaria is available globally and GSK is the manufacturer of that
DCGI approves AstraZeneca’s Lynparza for adjuvant treatment of patients with high-risk early breast…
New data from Olympia phase-III trial suggest that Olaparib demonstrated a statistically significant and clinically meaningful…
Dr Somani to continue as DCGI for next three months
He continues to hold the post with immediate effect from 16th August, 2022
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above
CORBEVAX is expected to be available as a Booster dose on the CoWIN App in public and private vaccination centres from August 12,…